0001209191-18-005220.txt : 20180124
0001209191-18-005220.hdr.sgml : 20180124
20180124175953
ACCESSION NUMBER: 0001209191-18-005220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180122
FILED AS OF DATE: 20180124
DATE AS OF CHANGE: 20180124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Bradley L
CENTRAL INDEX KEY: 0001400971
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 18546252
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-22
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001400971
Campbell Bradley L
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
0
1
0
0
Chief Operating Officer
Common Stock
2018-01-22
4
M
0
32500
10.21
A
186600
D
Common Stock
2018-01-22
4
S
0
32500
15.9191
D
154100
D
Stock Options (right to buy)
10.21
2018-01-22
4
M
0
32500
0.00
D
2018-02-05
Common Stock
32500
0
D
The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.73 to $16.24. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
All of the options were fully vested and exercisable as of January 22, 2018.
The options exercised were issued to Mr. Campbell in February 2008 and these options would have expired in February 2018.
/s/ Bradley L. Campbell
2018-01-24